Is Baduanjin beneficial and safe for the rehabilitation of patients with acute myocardial infarction undergoing percutaneous coronary intervention? A systematic review and meta-analysis of randomised
7 hours ago
- #Rehabilitation
- #Myocardial Infarction
- #Baduanjin
- Baduanjin improves left ventricular ejection fraction (LVEF) in AMI-PCI patients.
- Significant increase in 6-minute walk distance (6-MWD) observed with Baduanjin.
- Enhances quality of life (QOL) as measured by multiple questionnaires.
- Reduces symptoms of anxiety and depression across various scales.
- Safe intervention with potential to reduce cardiovascular adverse events.
- No increased risk of adverse events associated with Baduanjin.
- Further studies needed to confirm efficacy.